广州医药 ›› 2020, Vol. 51 ›› Issue (4): 110-113.DOI: 10.3969/j.issn.1000-8535.2020.04.024

• 论著 • 上一篇    下一篇

鼻咽癌个案管理模式的临床应用及成效评价

杜萍, 王志敏, 刘杰, 蔡莉莎, 何美清, 吴贝贝, 滕娟, 何佩仪   

  1. 广州市第一人民医院肿瘤科(广州 510180)
  • 收稿日期:2019-12-17 出版日期:2020-07-20 发布日期:2021-11-28
  • 通讯作者: 何佩仪,E-mail: pyhe0610@163.com

Clinical application and effect evaluation of case management model of nasopharyngeal carcinoma

DU Ping, WANG Zhimin, LIU Jie, CAI Lisha, HE Meiqing, WU Beibei, TENG Juan, HE Peiyi   

  1. Department of Oncology,Guangzhou First People's Hospital,Guangzhou 510180,China
  • Received:2019-12-17 Online:2020-07-20 Published:2021-11-28

摘要: 目的 探讨鼻咽癌个案管理模式,并评价临床中运用的效果。方法 回顾性将2017年8月—2018年4月93例新确诊的鼻咽癌患者作为对照组,按鼻咽癌患者的一般护理常规进行护理。2018年5月—2019年8月新确诊的鼻咽癌患者96例为实验组,实施个案管理比较两种方法的临床运用效果。结果 与对照组比,实验组诊断期完成检查时间和首次住院天数短、既定治疗计划完成率和治疗期间复诊依从性高,Ⅳ度骨髓抑制发生率低,差异均有统计学意义(P<0.05)。结论 鼻咽癌个案管理模式可为患者提供全程、连续性、高品质的护理,提高患者复诊依从性、提高治疗计划完成率,提高医疗护理质量,值得临床推广应用。

关键词: 鼻咽癌, 个案管理, 肿瘤, 既定治疗计划完成率, 复诊率, 骨髓抑制

Abstract: Objective To explore the case management mode of nasopharyngeal cancer (NPC) and evaluate the effect of clinical application. Methods 93 patients newly diagnosed NPC from August 2017 to April 2018 were used as the control group,and the general nursing routine was followed. 96 patients newly diagnosed NPC from May 2018 to August 2019 were taken as the experimental group,and accepted case management. Results Compared with the control group,the test time of the experimental group was shorter,the first hospital stay was shorter,the completion rate of treatment was higher,the patient's compliance of follow-up during treatment was better,incidence of grade Ⅳ myelosuppression was lower.The difference was statistically significant (P< 0.05). Conclusion The case management mode of NPC may provide seamless and high-quality nursing for NPC patients,improve the completion rate of treatment,improve the patient's compliance of follow-up and improve the quality of medical care,which is worthy of clinical application.

Key words: Nasopharyngeal cancer, Case management, Cancer, Completion rate of treatment, Further consultation rate, Myelosuppression